Kadmon Corporation, LLC
20 clinical trials · Sponsor
◉ Watch Kadmon Corporation, LLC
| Record | Firm | Date |
|---|---|---|
| A Phase I Study to Evaluate the Taste of Belumosudil Oral Suspensions & Assess Relative Bioavailability (NCT04735822) | Kadmon Corporation, LLC | 2020-10-26 |
| Human Absorption, Distribution and Metabolism Study (hAME) [14C]-KD025 (NCT03907540) | Kadmon Corporation, LLC | 2019-04-05 |
Track Kadmon Corporation, LLC automatically
Every clearance here is in the API, with alerts when new ones post.